BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.82 EUR
0.71%
Updated:
May 3, 2024
BRAIN Biotech AG
Other Operating Expenses
|
BRAIN Biotech AG
Other Operating Expenses Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Other Operating Expenses
-€9.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Other Operating Expenses
-€14.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evonik Industries AG
XETRA:EVK
|
Other Operating Expenses
€5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Covestro AG
XETRA:1COV
|
Other Operating Expenses
€73m
|
CAGR 3-Years
101%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Other Operating Expenses
-€71.6m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Other Operating Expenses
€74.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
See Also
What is BRAIN Biotech AG's Other Operating Expenses?
Other Operating Expenses
-9.6m
EUR
-9.6m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Other Operating Expenses amounts to -9.6m EUR.
What is BRAIN Biotech AG's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-1%
-1%
Over the last year, the Other Operating Expenses growth was -19%. The average annual Other Operating Expenses growth rates for BRAIN Biotech AG have been -15% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
